Impact of C34T P2Y12 ADP Receptor Polymorphism and Smoking Status on Cardiovascular Outcome in Coronary Artery Disease Patients Receiving Clopidogrel

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2016-05, Vol.210, p.161-163
Main Authors: Siasos, Gerasimos, Kioufis, Stamatios, Oikonomou, Evangelos, Zaromitidou, Marina, Maniatis, Kostas, Vavuranakis, Manolis, Kokkou, Eleni, Tousoulis, Dimitris
Format: Article
Language:English
Subjects:
ADP receptor polymorphism
Aged
Cardiovascular
Clopidogrel
Coronary artery disease
Coronary Artery Disease - drug therapy
Coronary Artery Disease - epidemiology
Coronary Artery Disease - genetics
Female
Follow-Up Studies
Humans
Male
Middle Aged
Polymorphism, Genetic - genetics
Purinergic P2Y Receptor Antagonists - therapeutic use
Receptors, Purinergic P2Y12 - genetics
Smoking
Smoking - drug therapy
Smoking - epidemiology
Smoking - genetics
Ticlopidine - analogs & derivatives
Ticlopidine - therapeutic use
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2016.02.129